Cerebrosterol

Cerebrosterol is a lipid of Sterol Lipids (ST) class. Cerebrosterol is associated with abnormalities such as nervous system disorder, Neurodegenerative Disorders, Alzheimer's Disease, Senile Plaques and Hypercholesterolemia. The involved functions are known as Blood - brain barrier function, Oxidation, 5-(carboxyamino)imidazole ribonucleotide mutase activity, cholesterol biosynthetic process and Anabolism. Cerebrosterol often locates in Hepatic, Body tissue, Autosome, brain tissue surgical material and Tissue membrane. The associated genes with Cerebrosterol are CYP27A1 gene, Alleles, INS gene, Apolipoprotein E4 and PLXNB1 gene. The related lipids are Sterols, 7-dehydrocholesterol, 27-hydroxycholesterol, 24-hydroxycholesterol and Dehydrocholesterols. The related experimental models are Mouse Model.

Cross Reference

Introduction

To understand associated biological information of Cerebrosterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Cerebrosterol?

Cerebrosterol is suspected in Hypercholesterolemia, nervous system disorder, Neurodegenerative Disorders, Alzheimer's Disease, Primary open angle glaucoma, Hypertensive disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Cerebrosterol

MeSH term MeSH ID Detail
Hypercholesterolemia D006937 91 associated lipids
Alzheimer Disease D000544 76 associated lipids
Nerve Degeneration D009410 53 associated lipids
Plaque, Amyloid D058225 19 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with Cerebrosterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Cerebrosterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Cerebrosterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Cerebrosterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Cerebrosterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Cerebrosterol?

Mouse Model

Mouse Model are used in the study 'Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation.' (Valenza M et al., 2007).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Cerebrosterol

Download all related citations
Per page 10 20 50 100 | Total 193
Authors Title Published Journal PubMed Link
pmid:
Prasad VV et al. Identification of 24-hydroxycholesterol in bovine adrenals in both free and esterified forms and in bovine brains as its sulfate ester. 1984 J. Steroid Biochem. pmid:6527537
Saucier SE et al. Hepatic uptake and metabolism of ingested 24-hydroxycholesterol and 24(S),25-epoxycholesterol. 1993 Biochim. Biophys. Acta pmid:8431485
Lund E et al. 24-, 25- and 27-hydroxylation of cholesterol by a purified preparation of 27-hydroxylase from pig liver. 1993 Biochim. Biophys. Acta pmid:8443234
Axelson M et al. Structural specificity in the suppression of HMG-CoA reductase in human fibroblasts by intermediates in bile acid biosynthesis. 1995 J. Lipid Res. pmid:7751816
Breuer O and Björkhem I Use of an 18O2 inhalation technique and mass isotopomer distribution analysis to study oxygenation of cholesterol in rat. Evidence for in vivo formation of 7-oxo-, 7 beta-hydroxy-, 24-hydroxy-, and 25-hydroxycholesterol. 1995 J. Biol. Chem. pmid:7657597
Lütjohann D et al. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. 1996 Proc. Natl. Acad. Sci. U.S.A. pmid:8790411
Meng LJ et al. High levels of (24S)-24-hydroxycholesterol 3-sulfate, 24-glucuronide in the serum and urine of children with severe cholestatic liver disease. 1997 J. Lipid Res. pmid:9186910
Zhang J et al. Metabolism of 27-, 25- and 24-hydroxycholesterol in rat glial cells and neurons. 1997 Biochem. J. pmid:9078259
Lehmann JM et al. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. 1997 J. Biol. Chem. pmid:9013544
Björkhem I et al. Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro. 1997 J. Biol. Chem. pmid:9374499
Björkhem I et al. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. 1998 J. Lipid Res. pmid:9717719
Babiker A and Diczfalusy U Transport of side-chain oxidized oxysterols in the human circulation. 1998 Biochim. Biophys. Acta pmid:9630709
Kölsch H et al. The neurotoxic effect of 24-hydroxycholesterol on SH-SY5Y human neuroblastoma cells. 1999 Brain Res. pmid:9914453
Norlin M et al. 24-hydroxycholesterol is a substrate for hepatic cholesterol 7alpha-hydroxylase (CYP7A). 2000 J. Lipid Res. pmid:11013305
Lütjohann D et al. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. 2000 J. Lipid Res. pmid:10681402
Russell DW Oxysterol biosynthetic enzymes. 2000 Biochim. Biophys. Acta pmid:11111082
Bretillon L et al. Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface. 2000 J. Lipid Res. pmid:10787445
Meaney S et al. Formation of oxysterols from different pools of cholesterol as studied by stable isotope technique: cerebral origin of most circulating 24S-hydroxycholesterol in rats, but not in mice. 2000 Biochim. Biophys. Acta pmid:10903480
Li-Hawkins J et al. Expression cloning of an oxysterol 7alpha-hydroxylase selective for 24-hydroxycholesterol. 2000 J. Biol. Chem. pmid:10748047
Papassotiropoulos A et al. Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease. 2000 Neuroreport pmid:10884051
Bretillon L et al. Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. 2000 Neurosci. Lett. pmid:11027840
Li D and Spencer TA Synthesis of 7alpha-hydroxy derivatives of regulatory oxysterols. 2000 Steroids pmid:10978732
Bodin K et al. Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4. 2001 J. Biol. Chem. pmid:11514559
Björkhem I et al. Oxysterols in the circulation of patients with the Smith-Lemli-Opitz syndrome: abnormal levels of 24S- and 27-hydroxycholesterol. 2001 J. Lipid Res. pmid:11254748
Bjorkhem I et al. From brain to bile. Evidence that conjugation and omega-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans. 2001 J. Biol. Chem. pmid:11463788
Kölsch H et al. Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17beta. 2001 J Neural Transm pmid:11475014
Meaney S et al. Evidence that the major oxysterols in human circulation originate from distinct pools of cholesterol: a stable isotope study. 2001 J. Lipid Res. pmid:11160367
Lütjohann D et al. Cholesterol dynamics in the foetal and neonatal brain as reflected by circulatory levels of 24S-hydroxycholesterol. 2001 Acta Paediatr. pmid:11440099
Bogdanovic N et al. On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells. 2001 Neurosci. Lett. pmid:11698143
Zhang Z et al. Key regulatory oxysterols in liver: analysis as delta4-3-ketone derivatives by HPLC and response to physiological perturbations. 2001 J. Lipid Res. pmid:11290837
Kölsch H et al. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease. 2002 Mol. Psychiatry pmid:12232784
Locatelli S et al. Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain. 2002 Arch. Neurol. pmid:11843691
Meir K et al. Human sterol 27-hydroxylase (CYP27) overexpressor transgenic mouse model. Evidence against 27-hydroxycholesterol as a critical regulator of cholesterol homeostasis. 2002 J. Biol. Chem. pmid:12119285
Leoni V et al. Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis. 2002 Neurosci. Lett. pmid:12383922
Schönknecht P et al. Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls. 2002 Neurosci. Lett. pmid:11983301
Papassotiropoulos A et al. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. 2002 Jan-Feb J Psychiatr Res pmid:11755458
Mast N et al. Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain. 2003 Biochemistry pmid:14640697
Norlin M et al. On the substrate specificity of human CYP27A1: implications for bile acid and cholestanol formation. 2003 J. Lipid Res. pmid:12777473
Teunissen CE et al. Decreased levels of the brain specific 24S-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients. 2003 Neurosci. Lett. pmid:12875910
Vega GL et al. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease. 2003 Arch. Neurol. pmid:12707064
Kölsch H et al. The role of 24S-hydroxycholesterol in Alzheimer's disease. 2003 J Nutr Health Aging pmid:12679839
Leoni V et al. Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers. 2003 J. Lipid Res. pmid:12562838
Teunissen CE et al. Combination of serum markers related to several mechanisms in Alzheimer's disease. 2003 Neurobiol. Aging pmid:12928047
Papassotiropoulos A et al. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. 2003 Arch. Neurol. pmid:12533085
Lütjohann D and von Bergmann K 24S-hydroxycholesterol: a marker of brain cholesterol metabolism. 2003 Pharmacopsychiatry pmid:14574622
Teunissen CE et al. Serum cholesterol, precursors and metabolites and cognitive performance in an aging population. 2003 Jan-Feb Neurobiol. Aging pmid:12493560
Holdenrieder S et al. Does brain specific 24S-hydroxycholesterol in plasma indicate the disruption of the blood-brain barrier in patients with ischemic stroke? 2004 Neurosci. Lett. pmid:15351449
Björkhem I and Meaney S Brain cholesterol: long secret life behind a barrier. 2004 Arterioscler. Thromb. Vasc. Biol. pmid:14764421
Kölsch H et al. Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients. 2004 Neurosci. Lett. pmid:15364416
Leoni V et al. Diagnostic use of cerebral and extracerebral oxysterols. 2004 Clin. Chem. Lab. Med. pmid:15061359
Burkard I et al. Determination of 24S- and 27-hydroxycholesterol in plasma by high-performance liquid chromatography-mass spectrometry. 2004 J. Lipid Res. pmid:14729854
Lütjohann D et al. High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs. 2004 Steroids pmid:15219793
Brown J et al. Differential expression of cholesterol hydroxylases in Alzheimer's disease. 2004 J. Biol. Chem. pmid:15148325
Heverin M et al. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. 2004 J. Lipid Res. pmid:14523054
Reiss AB et al. Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease. 2004 Neurobiol. Aging pmid:15212822
Vega GL et al. The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins. 2004 Curr Alzheimer Res pmid:15975088
Vogelvang TE et al. Effect of raloxifene and hormone therapy on serum markers of brain and whole-body cholesterol metabolism in postmenopausal women. 2005 Maturitas pmid:15780532
Papassotiropoulos A et al. A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease. 2005 J Clin Psychiatry pmid:16013913
Alexandrov P et al. 24S-hydroxycholesterol induces inflammatory gene expression in primary human neural cells. 2005 Neuroreport pmid:15931060
Teunissen CE et al. Biological markers in CSF and blood for axonal degeneration in multiple sclerosis. 2005 Lancet Neurol pmid:15620855
Sauder S et al. Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients. 2005 J Neural Transm pmid:15666037
Sovic A et al. Regulated expression of endothelial lipase by porcine brain capillary endothelial cells constituting the blood-brain barrier. 2005 J. Neurochem. pmid:15953354
Kölsch H et al. Polymorphism in ABCA1 influences CSF 24S-hydroxycholesterol levels but is not a major risk factor of Alzheimer's disease. 2006 Int. J. Mol. Med. pmid:16596262
Björkhem I Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. 2006 J. Intern. Med. pmid:17116000
Lukiw WJ Cholesterol and 24S-hydroxycholesterol trafficking in Alzheimer's disease. 2006 Expert Rev Neurother pmid:16734516
Lütjohann D Cholesterol metabolism in the brain: importance of 24S-hydroxylation. 2006 Acta Neurol. Scand., Suppl.c pmid:16866909
Abildayeva K et al. 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. 2006 J. Biol. Chem. pmid:16524875
Thelen KM et al. High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels. 2006 J Clin Pharmacol pmid:16809807
Panzenboeck U et al. Regulatory effects of synthetic liver X receptor- and peroxisome-proliferator activated receptor agonists on sterol transport pathways in polarized cerebrovascular endothelial cells. 2006 Int. J. Biochem. Cell Biol. pmid:16530456
Solfrizzi V et al. Circulating biomarkers of cognitive decline and dementia. 2006 Clin. Chim. Acta pmid:16139826
Kölsch H et al. Polymorphism in neuropeptide Y influences CSF cholesterol levels but is no major risk factor of Alzheimer's disease. 2006 J Neural Transm pmid:15959845
Björkhem I et al. Oxysterols and Alzheimer's disease. 2006 Acta Neurol. Scand., Suppl.c pmid:16866910
Karrenbauer VD et al. Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis. 2006 Clin Neurol Neurosurg pmid:16144738
Thelen KM et al. Effect of pravastatin on plasma sterols and oxysterols in men. 2006 Eur. J. Clin. Pharmacol. pmid:16385401
He X et al. Lovastatin modulates increased cholesterol and oxysterol levels and has a neuroprotective effect on rat hippocampal neurons after kainate injury. 2006 J. Neuropathol. Exp. Neurol. pmid:16825952
Leoni V et al. Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment? 2006 Apr 10-17 Neurosci. Lett. pmid:16406316
Chen W et al. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. 2007 Cell Metab. pmid:17189208
Karu K et al. Liquid chromatography-mass spectrometry utilizing multi-stage fragmentation for the identification of oxysterols. 2007 J. Lipid Res. pmid:17251593
Fujiyoshi M et al. 24S-hydroxycholesterol induces cholesterol release from choroid plexus epithelial cells in an apical- and apoE isoform-dependent manner concomitantly with the induction of ABCA1 and ABCG1 expression. 2007 J. Neurochem. pmid:17101031
Shafaati M et al. Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders. 2007 Neurosci. Lett. pmid:17822846
Björkhem I Rediscovery of cerebrosterol. 2007 Lipids pmid:17393206
Valenza M et al. Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation. 2007 Hum. Mol. Genet. pmid:17613541
Teunissen CE et al. 24S-hydroxycholesterol in relation to disease manifestations of acute experimental autoimmune encephalomyelitis. 2007 J. Neurosci. Res. pmid:17410599
Hansson M et al. Unique patient with cerebrotendinous xanthomatosis. Evidence for presence of a defect in a gene that is not identical to sterol 27-hydroxylase. 2007 J. Intern. Med. pmid:17444890
Ohtsuki S et al. Brain-to-blood elimination of 24S-hydroxycholesterol from rat brain is mediated by organic anion transporting polypeptide 2 (oatp2) at the blood-brain barrier. 2007 J. Neurochem. pmid:17868302
Burkard I et al. Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers. 2007 Atherosclerosis pmid:17107679
Famer D et al. Regulation of alpha- and beta-secretase activity by oxysterols: cerebrosterol stimulates processing of APP via the alpha-secretase pathway. 2007 Biochem. Biophys. Res. Commun. pmid:17532301
Joffre C et al. Oxysterols induced inflammation and oxidation in primary porcine retinal pigment epithelial cells. 2007 Curr. Eye Res. pmid:17453947
Umetani M et al. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. 2007 Nat. Med. pmid:17873880
Khripach VA et al. [A new synthesis of cerebrosterol and its 24-epimer from lithocholic acid]. 2007 Mar-Apr Bioorg. Khim. pmid:17476989
Weiner MF et al. Plasma 24S-hydroxycholesterol and other oxysterols in acute closed head injury. 2008 Brain Inj pmid:18568715
DeBarber AE et al. Liquid chromatography-tandem mass spectrometry determination of plasma 24S-hydroxycholesterol with chromatographic separation of 25-hydroxycholesterol. 2008 Anal. Biochem. pmid:18555788
Wang Y et al. The effect of 24S-hydroxycholesterol on cholesterol homeostasis in neurons: quantitative changes to the cortical neuron proteome. 2008 J. Proteome Res. pmid:18303831
Bang HJ et al. A comparison of the potential unfavorable effects of oxycholesterol and oxyphytosterol in mice: different effects, on cerebral 24S-hydroxychoelsterol and serum triacylglycerols levels. 2008 Biosci. Biotechnol. Biochem. pmid:19060413
Rantham Prabhakara JP et al. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells. 2008 J. Neurochem. pmid:19014385
Kristofiková Z et al. Complex of amyloid beta peptides with 24-hydroxycholesterol and its effect on hemicholinium-3 sensitive carriers. 2008 Neurochem. Res. pmid:17717740
Leoni V et al. Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease. 2008 Brain pmid:18772220
Leoni V Oxysterols as markers of neurological disease--a review. 2009 Scand. J. Clin. Lab. Invest. pmid:19199127
Liao WL et al. Steroid and protein ligand binding to cytochrome P450 46A1 as assessed by hydrogen-deuterium exchange and mass spectrometry. 2009 Biochemistry pmid:19317426